Response to Salvage Therapy, The Main Prognosis Factor in Patients with Refractory or Relapsed Diffuse Large B-Cell Lymphoma Treated with R-ESHAP and Autologous Stem Cell Transplantation

被引：0
|
作者：
Salido Toimil, F. [1 ]
Torres Carrete, P. [1 ]
Deben Ariznavarreta, G. [1 ]
Varela Gomez, M. R. [1 ]
Lopez Fernandez, M. F. [1 ]
Noriega Concepcion, V. [1 ]
机构：
[1] Complexo Hosp Univ A Coruna, La Coruna, Spain
来源：
BONE MARROW TRANSPLANTATION | 2016年 / 51卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P352
引用
收藏
页码：S300 / S301
页数：2
相关论文
共 50 条
  • [21] Salvage therapy for relapsed/refractory diffuse large B cell lymphoma
    Sesbadri, Tara
    Kuruvilla, Fohn
    Crump, Michael
    Keating, Armand
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (03) : 259 - 267
  • [22] Autologous stem cell transplantation in patients with relapsed / refractory diffuse large B-cell lymphoma - a retrospective single-center analysis
    Berning, P.
    Wullenkord, R.
    Bergmann, S.
    Huesken, A. -C.
    Schliemann, C.
    Mesters, R.
    Kessler, T.
    Schmitz, N.
    Berdel, W. E.
    Lenz, G.
    Stelljes, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 79 - 80
  • [23] Role of Roflumilast Combined with ESHAP Chemotherapy in Relapsed/Refractory Patients with Diffuse Large B-Cell Lymphoma
    Kim, Do Young
    Nam, Jehyun
    Chung, Joo-seop
    Kim, Sang-Woo
    Shin, Ho-Jin
    CANCER RESEARCH AND TREATMENT, 2022, 54 (01): : 301 - 313
  • [24] Zanubrutinib Plus Salvage Chemotherapy in Refractory/Relapsed Diffuse Large B-Cell Lymphoma Patients Non-Candidate for Autologous Stem Cell Transplantation: A Retrospective Study
    He, Sha
    Sun, Jie
    Zhong, Dani
    Rong, Chao
    Liao, Chengcheng
    Tan, Xiaohong
    BLOOD, 2023, 142
  • [25] Outcomes of salvage chemotherapy and autologous stem cell transplantation for relapsed or refractory primary mediastinal large B cell lymphoma are not inferior to bulky diffuse large B cell lymphoma
    Kuruvilla, J
    Nagy, T
    Pintilie, M
    Keating, A
    Crump, M
    ANNALS OF ONCOLOGY, 2005, 16 : 100 - 100
  • [26] Salvage therapy for relapsed or refractory diffuse large B-cell lymphoma: impact of prior rituximab
    Sud, Rohit
    Friedberg, Jonathan W.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 (12): : 1776 - 1780
  • [27] Efficacy of Salvage Radiotherapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma
    Wang, S.
    Chen, J. Y.
    Cao, W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E471 - E472
  • [28] Efficacy of salvage radiotherapy for relapsed/refractory diffuse large B-cell lymphoma
    Wang, Shu-Bei
    Chen, Jia-Yi
    Zhao, Wei-Li
    Kirova, Youlia M.
    Cao, Wei-Guo
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 (04) : 1019 - 1026
  • [29] Autologous Stem Cell Transplant in Fit Patients with Late Relapsed Diffuse Large B-Cell Lymphoma That Responded to Salvage Chemotherapy
    Tun, Aung M.
    Maliske, Seth
    Wang, Yucai
    Inwards, David James
    Habermann, Thomas M.
    Micallef, Ivana
    Porrata, Luis
    Paludo, Jonas
    Villasboas, J. C.
    Rosenthal, Allison C.
    Kharfan-Dabaja, Mohamed A.
    Ansell, Stephen M.
    Nowakowski, Grzegorz S.
    Farooq, Umar
    Johnston, Patrick B.
    BLOOD, 2023, 142
  • [30] Outcomes of allogeneic hematopoietic stem cell transplantation for relapsed or refractory diffuse large B-cell lymphoma
    Kato, Koji
    Sugio, Takeshi
    Ikeda, Takashi
    Yoshitsugu, Kanako
    Miyazaki, Kana
    Suzumiya, Junji
    Yamamoto, Go
    Kim, Sung-Won
    Ikegame, Kazuhiro
    Uehara, Yasufumi
    Mori, Yasuo
    Ishikawa, Jun
    Hiramoto, Nobuhiro
    Eto, Tetsuya
    Nakazawa, Hideyuki
    Kobayashi, Hikaru
    Serizawa, Kentaro
    Onizuka, Makoto
    Fukuda, Takahiro
    Atsuta, Yoshiko
    Suzuki, Ritsuro
    BONE MARROW TRANSPLANTATION, 2024, 59 (03) : 306 - 314
12345